…
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 82.51M | 73.03M | 53.90M | 52.72M | 21.20M |
| Net income | 68.31M | 58.98M | 44.92M | 41.79M | 15.89M |
| Selling general administrative | 77.44M | 62.22M | 49.66M | 55.63M | 29.48M |
| Gross profit | 170.41M | 146.69M | 112.22M | 90.26M | 51.11M |
| Reconciled depreciation | 19.15M | 14.71M | 11.20M | 11.89M | 8.41M |
| Ebit | 92.32M | 81.09M | 57.55M | 21.64M | 21.22M |
| Ebitda | 115.74M | 95.80M | 68.95M | 33.53M | 30.12M |
| Depreciation and amortization | 23.43M | 14.71M | 11.41M | 11.89M | 8.90M |
| Non operating income net other | - | - | - | 0.08M | 0.07M |
| Operating income | 92.34M | 80.90M | 57.66M | 21.64M | 21.22M |
| Other operating expenses | 510.46M | 423.52M | 342.41M | 309.33M | 184.69M |
| Interest expense | 9.80M | 8.06M | 3.65M | 2.76M | 0.09M |
| Tax provision | 14.20M | 14.04M | 10.00M | 10.93M | 5.32M |
| Interest income | - | - | - | - | 0.05M |
| Net interest income | -9.80M | -8.06M | -3.76M | -2.76M | -0.04M |
| Non recurring | - | - | - | -5.12M | 0.42M |
| Income tax expense | 14.20M | 14.04M | 8.98M | 10.93M | 5.32M |
| Total revenue | 602.80M | 504.42M | 400.07M | 353.79M | 206.32M |
| Total operating expenses | 78.07M | 65.80M | 54.56M | 45.80M | 29.48M |
| Cost of revenue | 432.39M | 357.73M | 287.85M | 263.53M | 155.21M |
| Total other income expense net | -9.82M | -7.87M | -3.76M | 31.08M | -0.01M |
| Net income from continuing ops | 68.31M | 58.98M | 41.78M | 41.79M | 15.89M |
| Net income applicable to common shares | - | - | - | 41.79M | 15.89M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 665.74M | 629.00M | 404.14M | 377.54M | 334.13M |
| Intangible assets | 140.85M | 144.25M | 64.12M | 68.36M | 67.58M |
| Other current assets | 5.62M | 4.30M | 3.43M | 3.24M | 3.38M |
| Total liab | 241.86M | 286.24M | 118.05M | 140.00M | 139.69M |
| Total stockholder equity | 423.88M | 342.76M | 286.09M | 237.54M | 194.45M |
| Deferred long term liab | - | - | - | - | 7.60M |
| Other current liab | 28.80M | 30.41M | 22.09M | 27.12M | 13.61M |
| Common stock | 0.08M | 0.08M | 0.08M | 0.08M | 0.07M |
| Capital stock | 0.08M | 0.08M | 0.08M | 0.08M | 0.07M |
| Retained earnings | 374.81M | 306.50M | 247.52M | 202.60M | 160.81M |
| Other liab | - | - | - | 22.84M | 104.98M |
| Good will | 197.40M | 189.66M | 113.26M | 113.03M | 107.91M |
| Other assets | 47.65M | - | - | 9.23M | 14.75M |
| Cash | 20.30M | 13.45M | 5.26M | 4.45M | 11.12M |
| Total current liabilities | 74.86M | 76.30M | 58.21M | 55.76M | 34.71M |
| Current deferred revenue | 4.24M | 4.67M | 6.62M | 4.68M | 4.25M |
| Net debt | 134.18M | 192.58M | 40.77M | 50.55M | 73.24M |
| Short term debt | 17.54M | 16.73M | 7.22M | 4.00M | 6.24M |
| Short long term debt | 12.50M | 12.50M | 4.00M | 4.00M | 4.00M |
| Short long term debt total | 154.48M | 206.03M | 46.04M | 55.00M | 84.36M |
| Other stockholder equity | 45.28M | 40.35M | 38.23M | 35.48M | 33.56M |
| Property plant equipment | - | - | - | 58.07M | 56.57M |
| Total current assets | 201.00M | 194.94M | 144.63M | 116.35M | 87.32M |
| Long term investments | 6.93M | 6.81M | - | - | - |
| Net tangible assets | - | - | - | 237.54M | 18.96M |
| Net receivables | 88.22M | 89.66M | 65.75M | 55.12M | 39.38M |
| Long term debt | 122.95M | 176.88M | 28.00M | 51.00M | 71.00M |
| Inventory | 86.86M | 87.54M | 70.19M | 53.54M | 33.44M |
| Accounts payable | 24.29M | 24.27M | 22.29M | 19.96M | 10.61M |
| Accumulated other comprehensive income | 3.71M | -4.17M | 0.27M | -0.61M | - |
| Common stock total equity | - | - | - | 0.08M | 0.07M |
| Retained earnings total equity | - | - | - | 202.60M | 160.81M |
| Treasury stock | - | - | - | -0.59M | -0.59M |
| Non currrent assets other | 10.91M | 6.62M | 5.79M | 20.29M | 5.43M |
| Non current assets total | 464.73M | 434.05M | 259.50M | 261.20M | 246.81M |
| Capital lease obligations | 19.03M | 16.66M | 14.04M | 13.37M | 9.36M |
| Long term debt total | - | - | - | - | 71.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -210.16M | -10.70M | 1.29M | -101.46M |
| Change to liabilities | - | - | - | 16.28M | -0.33M |
| Total cashflows from investing activities | -27.60M | -210.16M | -10.49M | 1.29M | -101.46M |
| Net borrowings | -53.98M | 157.30M | -23.06M | -20.00M | 74.84M |
| Total cash from financing activities | -58.16M | 152.39M | -30.02M | -25.89M | 74.05M |
| Change to operating activities | - | - | - | 2.91M | -1.67M |
| Net income | 68.31M | 58.98M | 44.92M | 41.79M | 15.89M |
| Change in cash | 6.85M | 8.19M | 0.81M | -6.67M | -13.12M |
| Begin period cash flow | 13.45M | 5.26M | 4.45M | 11.12M | 24.23M |
| End period cash flow | 20.30M | 13.45M | 5.26M | 4.45M | 11.12M |
| Total cash from operating activities | 91.91M | 66.59M | 41.33M | 17.74M | 14.29M |
| Depreciation | 19.15M | 14.71M | 11.41M | 11.89M | 8.41M |
| Other cashflows from investing activities | 0.05M | -3.03M | 0.00M | 15.07M | -96.06M |
| Change to inventory | 3.90M | -4.69M | -16.57M | -19.61M | -4.50M |
| Change to account receivables | 4.79M | -2.19M | -12.11M | -16.86M | -9.42M |
| Sale purchase of stock | - | -4.95M | -2.64M | 0.39M | 0.16M |
| Other cashflows from financing activities | -4.43M | -0.19M | -7.70M | 37.78M | 74.08M |
| Change to netincome | - | - | - | -13.46M | 0.62M |
| Capital expenditures | 12.93M | 9.66M | 10.49M | 13.78M | 5.39M |
| Change receivables | - | - | - | -16.86M | -7.75M |
| Cash flows other operating | - | - | - | -2.28M | 1.95M |
| Cash and cash equivalents changes | - | - | - | -6.86M | -13.12M |
| Change in working capital | -9.70M | -16.34M | -24.13M | -22.47M | -10.63M |
| Stock based compensation | 8.85M | 6.84M | 4.64M | 3.21M | 2.43M |
| Other non cash items | 0.18M | 1.06M | 3.67M | -11.96M | -0.01M |
| Free cash flow | 78.98M | 56.94M | 30.84M | 3.96M | 8.90M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| UFPT UFP Technologies Inc |
3.65 1.22% |
303.47 | 30.04 | 21.83 | 3.38 | 4.66 | 3.61 | 19.65 |
| ABT Abbott Laboratories |
-0.03 0.03% |
109.93 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
-3.04 2.90% |
101.80 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-9.21 2.75% |
325.87 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
-2.15 4.12% |
49.85 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
| Name | Title | Year Born |
|---|---|---|
| Mr. R. Jeffrey Bailly | Chairman of Directors, Pres & CEO | 1962 |
| Mr. Ronald J. Lataille | CFO, Sr. VP & Treasurer | 1962 |
| Mr. Christopher P. Litterio Esq. | Gen. Counsel, Sec. & Sr. VP of HR | 1963 |
| Mr. Mitchell Caplan Rock | Pres of MedTech | 1968 |
| Mr. Steve Cardin | VP & COO of MedTech | NA |
| Mr. R. Jeffrey Bailly | CEO & Chairman | 1962 |
| Mr. Mitchell Caplan Rock | President | 1968 |
| Mr. Ronald J. Lataille | CFO, Senior VP & Treasurer | 1962 |
| Mr. Christopher P. Litterio Esq. | General Counsel, Secretary & Senior VP of Human Resources | 1963 |
| Mr. Steven G. Cardin | VP & COO of MedTech | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.